RENAL AID: Understanding Kidney Diseases

This study, called RENAL AID, is collecting information from a large group of people with various kidney diseases, including chronic kidney failure, diabetic nephropathy (kidney damage from diabetes), lupus nephritis (kidney inflammation from lupus), and glomerulonephritis (inflammation of the kidney's filtering units). The goal is to understand what causes these diseases to get worse, how people respond to treatments, and to find new ways to identify kidney problems without needing a biopsy. Researchers are looking at how different factors, including a mechanism called RAF, might predict disease progression over up to 10 years. You can join if you are 18 or older and willing to provide consent. Some participants will have had a kidney biopsy, while others may have diabetes and kidney disease without a recent biopsy.

Study design
This is an observational study, meaning researchers will collect information without giving any specific treatments. It aims to include 2000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for changes in disease progression for up to 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01802034

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Recruiting
Not specifiedAges 18+Observational
The Rogosin Institute
~2,000 participants
Updated 2025-04-04 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in disease progression
Measured over Up to 10 years
Kidney Diseases
Kidney Failure, Chronic
Diabetic Nephropathy
Lupus Nephritis
Glomerulonephritis, IGA
1 sites across 1 states
New York1
  • Alan S Perlman, M.D. · PRINCIPAL_INVESTIGATOR · The Rogosin Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males or females
18 years of age and older
Willing and able to provide informed consent
Previously had a kidney biopsy and the tissue is not stored in this biorepository; or
Have diabetes and kidney disease and have not had a kidney biopsy
  • Change in disease progressionUp to 10 years